Role of Fas mediated apoptosis in the process of autoimmune thyroid diseases : possible involvement of Fas ligand (FasL) expression in breakdown of "immunoprevileged site" formation

Fas 介导的细胞凋亡在自身免疫性甲状腺疾病过程中的作用:Fas 配体 (FasL) 表达可能参与“免疫抑制位点”形成的破坏

基本信息

  • 批准号:
    11671091
  • 负责人:
  • 金额:
    $ 1.79万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Fas ligand (FasL) is expressed in thyrocytes, and appear to plays an important role to make normal thyroid tissue to be "immunoprevileged site." Since IL-1β is strongly expressed in Graves' thyroid tissue, we tried to determine the possible involvement of IL-1β in the process of Graves' disease regarding Fas/FasL interaction between thyrocytes and T cells.Immunohistochemical analysis has shown that the percentage of FasL-positive thyrocytes in Graves' thyroids was less than in normal thyroids. In contrast, many thyrocytes in Graves' disease expressed Fas molecule. Treatment of thyrocytes with IL-1β in vitro increased Fas expression but markedly reduced FasL expression. Activated T cells in vitro, which strongly expressed FasL, induced Fas-mediated apoptosis in IL-1β stimulated thyrocytes.Massive CD4^+ T cell infiltration has been demonstrated in Graves' thyroid tissue. Western blotting analysis revealed that FasL expression of thyroid infiltrating CD4^+ T cells was significantly intense than that of peripheral blood (PB) CD4^+ T cells. Although the cytotoxic activity of PB CD4^+ T cells toward IL-1β stimulated thyrocytes was very week, thyroid infiltrating CD4^+ T cells of Graves' disease apparently induced Fas mediated apoptosis toward IL-1β stimulated thyrocytes. Fas expression was also markedly increased in thyroid-infiltrating CD4^+ T cells, however, the cells were resistant to Fas-mediated apoptosis, probably due to the increased expression of Bcl-x2.Previous studies have shown that IL-1β increases the expression of adhesion molecules and stimulates the migration of activated T cells from peripheral blood into thyroid tissues. In addition, our present results indicate that IL-1β increases the sensitivity of Fas mediated apoptosis of thyrocytes induced by CD4^+ T cells, which may attribute to the breakdown of "immunoprevileged site" formation in thyroid tissues of Graves' disease.
Fas配体(FasL)在甲状腺细胞中表达,在使正常甲状腺组织成为“免疫排斥部位”中起重要作用。“由于IL-1β在Graves'甲状腺组织中强烈表达,我们试图确定IL-1β在Graves'病过程中可能参与甲状腺细胞和T细胞之间的Fas/FasL相互作用。免疫组织化学分析显示,Graves'甲状腺中FasL阳性甲状腺细胞的百分比低于正常甲状腺。而Graves病患者甲状腺细胞多表达Fas分子。IL-1β体外处理甲状腺细胞可增加Fas表达,但明显降低FasL表达。在IL-1β刺激的甲状腺细胞中,体外活化的T细胞强表达FasL,诱导Fas介导的细胞凋亡,Graves甲状腺组织中可见大量的CD 4 ^+ T细胞浸润。Western blotting分析显示,甲状腺浸润的CD 4 ^+ T细胞的FasL表达明显强于外周血(PB)CD 4 ^+ T细胞。虽然PB CD 4 ^+ T细胞对IL-1β刺激的甲状腺细胞的杀伤活性很弱,但Graves病甲状腺浸润的CD 4 ^+ T细胞明显诱导Fas介导的IL-1β刺激的甲状腺细胞凋亡。在甲状腺浸润的CD 4 ^+ T细胞中Fas表达也明显增加,但这些细胞对Fas介导的凋亡具有抵抗性,这可能与Bcl-x2表达增加有关。既往研究表明,IL-1β可增加粘附分子的表达,刺激活化的T细胞从外周血向甲状腺组织迁移。另外,IL-1β可增强Fas介导的CD 4 ^+ T细胞诱导的甲状腺细胞凋亡的敏感性,这可能是由于IL-1β破坏了Graves病甲状腺组织中“免疫排斥位点”的形成。

项目成果

期刊论文数量(49)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yasuyo Abe: "Etidronate inhibits human osteoblast apoptosis by inhibition of proapoptotic factor (s) produced by activated T cells"J Lab Clin Med. 136・5. 344-354 (2000)
Yasuyo Abe:“依替膦酸通过抑制活化的 T 细胞产生的促凋亡因子来抑制人成骨细胞凋亡”J Lab Clin Med 136·5 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hideki Nakamura: "Expression and function of X chromosome-linked inhibitor of apoptosis protein in Sjogren's syndrome"Lab Invest. 80・9. 1421-1427 (2000)
Hideki Nakamura:“干燥综合征中X染色体连锁凋亡抑制蛋白的表达和功能”Lab Invest 80・9(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasuyo Abe: "Etidronate inhibits human osteoblast apoptosis by inhibition of proapoptotic factor (s) produced by activated T cells."J Lab Clin Med. 136・5. 344-354 (2000)
Yasuyo Abe:“依替膦酸通过抑制激活的 T 细胞产生的促凋亡因子来抑制人成骨细胞凋亡。”J Lab Clin Med 136・5(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Satoshi Urayama: "Effect of vitamin K2 on osteoblast apoptosis : Vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine."J Lab Clin Med. 136. 181-193 (2000)
Satoshi Urayama:“维生素 K2 对成骨细胞凋亡的影响:维生素 K2 抑制 Fas、蛋白酶体抑制剂、依托泊苷和星形孢菌素诱导的人成骨细胞凋亡细胞死亡。”J Lab Clin Med。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Shima: "Activation of caspase-8 in trasnforming growth factor-beta induced apoptosis of human hepatoma cells"Hepatology. 30. 1215-1222 (1999)
Y.Shima:“转化生长因子-β 诱导人肝癌细胞凋亡中 caspase-8 的激活”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EGUCHI Katsumi其他文献

EGUCHI Katsumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EGUCHI Katsumi', 18)}}的其他基金

Role of innate immunity on initiation of autoimmune diseases and its regulation
先天免疫在自身免疫性疾病发生中的作用及其调控
  • 批准号:
    15390316
  • 财政年份:
    2003
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of suscebility genes and pathogenesis of HTLV-I-associated Sjogren's syndrome
HTLV-I相关干燥综合征易感基因及发病机制分析
  • 批准号:
    13557042
  • 财政年份:
    2001
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms of immunoregulation by serine proteinase inhibitor and its application of therapy for rheumatic disease
丝氨酸蛋白酶抑制剂的免疫调节机制及其在风湿病治疗中的应用
  • 批准号:
    13670461
  • 财政年份:
    2001
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HTLV-I on pathegenesis of Sjogren's syndrome
HTLV-I 在干燥综合征发病机制中的作用
  • 批准号:
    09670482
  • 财政年份:
    1997
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ROLE OF HUMAN T LYMPHOTROPIC VIRUS TYPE I ON PATHOGENESIS OF SJOGREN'S SYNDROME
I型人类T淋巴细胞病毒在干燥综合征发病机制中的作用
  • 批准号:
    07670534
  • 财政年份:
    1995
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of adult T cell lymphotropic virus 1 on pathogenesis of Sjogren's syndrome.
成人 T 细胞嗜淋巴细胞病毒 1 在干燥综合征发病机制中的作用。
  • 批准号:
    05670426
  • 财政年份:
    1993
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Role of HTLV-I infection in development of chronic inflammatory arthropathy.
HTLV-I 感染在慢性炎症性关节病发展中的作用。
  • 批准号:
    02670285
  • 财政年份:
    1990
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Elucidation of clinicopathological significance of Siglec1 in Graves' disease and clinical application of Siglec1
阐明Siglec1在格雷夫斯病中的临床病理意义及其临床应用
  • 批准号:
    23K08015
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Spatial transcriptome analysis of thyroid-infiltrating autoreactive T cells in Graves' disease
格雷夫斯病甲状腺浸润自身反应性 T 细胞的空间转录组分析
  • 批准号:
    23K19596
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Pathophysiology and therapeutic application of refractory Graves' disease by peripheral blood immunophenotyping
外周血免疫表型分析难治性格雷夫斯病的病理生理学和治疗应用
  • 批准号:
    23K15423
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
To clarify the autoreactive T cells in Graves' Disease using single cell analysis
使用单细胞分析阐明格雷夫斯病中的自身反应性 T 细胞
  • 批准号:
    22K16417
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Resilience of women living with Graves' disease - Recovery from stress and growth-
患有格雷夫斯病的女性的复原力 - 从压力和成长中恢复 -
  • 批准号:
    22K10815
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Plasma-cell depletion therapy for severe Graves' disease
严重格雷夫斯病的浆细胞耗竭疗法
  • 批准号:
    MR/V005898/1
  • 财政年份:
    2021
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Research Grant
Investigating the Role of Circulating Exosomes in the Aggravation Mechanisms of Graves' Disease
研究循环外泌体在格雷夫斯病加重机制中的作用
  • 批准号:
    20K17523
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular determinants of immune tolerance in Graves' disease
格雷夫斯病免疫耐受的分子决定因素
  • 批准号:
    MR/S001611/1
  • 财政年份:
    2018
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Fellowship
Does Stress cause Graves' disease?
压力会导致格雷夫斯病吗?
  • 批准号:
    nhmrc : 1128295
  • 财政年份:
    2017
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Project Grants
Epitope specific therapy in Graves' disease
格雷夫斯病的表位特异性治疗
  • 批准号:
    17K09888
  • 财政年份:
    2017
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了